Genomic Valley Biotech Announces Promoter Stake Sale and Open Offer
Genomic Valley Biotech Ltd 路 Others (Uncategorized) 路 20 Oct 2026, 9:42 pm
Genomic Valley Biotech Announces Promoter Stake Sale and Open Offer Promoter Yogesh Agrawal executed a Share Purchase Agreement on 19th Oct'26 to sell his entire stake of 14,07,000 equity shares (46.06% of voting share capital) in Genomic Valley Biotech Limited to Pankaj Grover and Abhisek Gupta. The transaction will trigger a mandatory open offer under SEBI SAST Regulations. Following the completion of the open offer and transaction, the acquirers will gain management control and be reclassified as promoters, while existing promoter directors will resign from the board.
Original exchange filing (PDF)
More announcements from Genomic Valley Biotech Ltd
- Fintellectual Corporate Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Public Shareholders of Genomic Valley Biotech .... 路 03 Nov 2026
- Please find enclosed herewith unaudited standalone financial results for the quarter and half yearly ended on September 30, 2026 路 30 Oct 2026
- Please find enclosed herewith Outcome of Board Meeting Pursuant to regulation 30 of Sebi (LODR)Regulation, 2015 held on today i.e. 30th October 2026 路 30 Oct 2026
- Fintellectual Corporate Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 3(1) and Regulation 4 read with Regulation .... 路 27 Oct 2026
- Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve the unaudited financial .... 路 30 Oct 2026
- Fintellectual Corporate Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Public Announcement ("PA") under Regulation 3(1) and Regulation 4 read with Regulation .... 路 19 Oct 2026
- Intimation of approval of Extension of time for holding Annual General Meeting (AGM) of the company for the financial year ended on 31st March 2026, pursuant to regulation 30 of SEBI (Listing .... 路 31 Aug 2026
- Unaudited financial results for Quarter ended on 30 June 2026. 路 14 Aug 2026
